Biora Therapeutics IncNASDAQ:BIORNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5995
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.6000/ 6
- Ask / Lots0.6499/ 10
- Open / Previous Close0.0000 / 0.5995
- Day Range---
- 52 Week Range
- Volume99
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BIOR |
|---|---|---|
| 09:32 ET | 8568 | 0.678899 |
| 09:34 ET | 100 | 0.65 |
| 09:36 ET | 1700 | 0.65 |
| 09:38 ET | 10800 | 0.65 |
| 09:39 ET | 500 | 0.6788 |
| 09:41 ET | 2232 | 0.66 |
| 09:43 ET | 200 | 0.66 |
| 09:45 ET | 495 | 0.6675 |
| 09:50 ET | 400 | 0.66 |
| 09:54 ET | 200 | 0.675 |
| 09:56 ET | 1200 | 0.66 |
| 09:57 ET | 600 | 0.65 |
| 09:59 ET | 4194 | 0.66 |
| 10:01 ET | 1478 | 0.678899 |
| 10:03 ET | 248 | 0.66 |
| 10:06 ET | 739 | 0.67 |
| 10:08 ET | 3639 | 0.66 |
| 10:10 ET | 11300 | 0.6601 |
| 10:12 ET | 8590 | 0.65 |
| 10:14 ET | 769 | 0.65 |
| 10:15 ET | 10100 | 0.645 |
| 10:17 ET | 2521 | 0.645 |
| 10:19 ET | 3050 | 0.6555 |
| 10:24 ET | 1300 | 0.645 |
| 10:30 ET | 100 | 0.645 |
| 10:32 ET | 300 | 0.655 |
| 10:35 ET | 100 | 0.655 |
| 10:39 ET | 11820 | 0.6468 |
| 10:46 ET | 10800 | 0.645 |
| 10:48 ET | 100 | 0.645 |
| 10:50 ET | 200 | 0.645 |
| 10:51 ET | 100 | 0.645 |
| 10:53 ET | 100 | 0.65 |
| 10:55 ET | 1420 | 0.645 |
| 10:57 ET | 2400 | 0.6478 |
| 11:02 ET | 100 | 0.646 |
| 11:06 ET | 900 | 0.645 |
| 11:08 ET | 100 | 0.645 |
| 11:13 ET | 100 | 0.6451 |
| 11:22 ET | 800 | 0.6506 |
| 11:24 ET | 7407 | 0.6452 |
| 11:27 ET | 21953 | 0.6452 |
| 11:33 ET | 1200 | 0.6452 |
| 11:36 ET | 100 | 0.6452 |
| 11:38 ET | 100 | 0.6452 |
| 11:42 ET | 400 | 0.6452 |
| 11:45 ET | 200 | 0.6451 |
| 11:47 ET | 400 | 0.6451 |
| 11:56 ET | 1100 | 0.650051 |
| 11:58 ET | 377 | 0.6451 |
| 12:02 ET | 100 | 0.6451 |
| 12:05 ET | 600 | 0.6451 |
| 12:07 ET | 1000 | 0.650001 |
| 12:14 ET | 1900 | 0.654 |
| 12:20 ET | 3550 | 0.646 |
| 12:30 ET | 100 | 0.645 |
| 12:39 ET | 1400 | 0.6524 |
| 12:41 ET | 766 | 0.6548 |
| 12:50 ET | 2200 | 0.6452 |
| 12:52 ET | 100 | 0.65 |
| 12:54 ET | 100 | 0.645 |
| 01:19 ET | 4400 | 0.65 |
| 01:21 ET | 280 | 0.66 |
| 01:26 ET | 11099 | 0.65 |
| 01:28 ET | 16219 | 0.645 |
| 01:30 ET | 1700 | 0.6451 |
| 01:32 ET | 1073 | 0.6451 |
| 01:33 ET | 681 | 0.6451 |
| 01:35 ET | 300 | 0.6451 |
| 01:39 ET | 100 | 0.6451 |
| 01:42 ET | 2200 | 0.6451 |
| 01:44 ET | 250 | 0.65255 |
| 01:48 ET | 400 | 0.66 |
| 01:50 ET | 74737 | 0.63 |
| 01:51 ET | 16000 | 0.63 |
| 01:53 ET | 588 | 0.6355 |
| 01:55 ET | 26807 | 0.621 |
| 01:57 ET | 200 | 0.62 |
| 02:00 ET | 200 | 0.63 |
| 02:02 ET | 300 | 0.6505 |
| 02:04 ET | 1100 | 0.64 |
| 02:06 ET | 35346 | 0.612 |
| 02:08 ET | 100 | 0.6112 |
| 02:11 ET | 9280 | 0.6006 |
| 02:13 ET | 30671 | 0.599 |
| 02:15 ET | 1065 | 0.5911 |
| 02:18 ET | 2200 | 0.598 |
| 02:20 ET | 8273 | 0.5864 |
| 02:22 ET | 2586 | 0.6 |
| 02:24 ET | 11431 | 0.604 |
| 02:31 ET | 21523 | 0.6246 |
| 02:33 ET | 4300 | 0.6041 |
| 02:36 ET | 400 | 0.6243 |
| 02:38 ET | 300 | 0.6 |
| 02:40 ET | 500 | 0.601 |
| 02:42 ET | 400 | 0.6 |
| 02:44 ET | 137 | 0.602 |
| 02:45 ET | 100 | 0.603 |
| 02:47 ET | 5445 | 0.602 |
| 02:49 ET | 300 | 0.6232 |
| 02:51 ET | 200 | 0.609 |
| 02:54 ET | 200 | 0.615 |
| 02:56 ET | 300 | 0.615 |
| 02:58 ET | 1964 | 0.6021 |
| 03:00 ET | 100 | 0.602 |
| 03:02 ET | 100 | 0.602 |
| 03:03 ET | 200 | 0.602 |
| 03:05 ET | 100 | 0.602 |
| 03:07 ET | 1550 | 0.602 |
| 03:09 ET | 550 | 0.6021 |
| 03:12 ET | 100 | 0.62 |
| 03:16 ET | 100 | 0.602 |
| 03:20 ET | 724 | 0.61 |
| 03:21 ET | 100 | 0.61 |
| 03:23 ET | 200 | 0.6101 |
| 03:27 ET | 2200 | 0.61 |
| 03:30 ET | 100 | 0.61 |
| 03:39 ET | 200 | 0.602 |
| 03:41 ET | 100 | 0.6021 |
| 03:43 ET | 31274 | 0.6 |
| 03:45 ET | 735 | 0.60005 |
| 03:48 ET | 3812 | 0.6 |
| 03:50 ET | 8942 | 0.59 |
| 03:52 ET | 1402 | 0.585 |
| 03:54 ET | 1500 | 0.585001 |
| 03:56 ET | 2200 | 0.5911 |
| 03:57 ET | 2507 | 0.5995 |
| 03:59 ET | 1587 | 0.5995 |
Apr 8, 2024
Biora Therapeutics Announces New Patent Covering its BioJet(TM) Liquid Jet Delivery Technology, from 8:00AM ET on Monday Apr 08, 2024 by Dow Jones
8:00AM ET on Monday Apr 08, 2024 by Dow Jones
Apr 4, 2024
Biora Therapeutics Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap(TM) Platform Development, from 8:00AM ET on Thursday Apr 04, 2024 by Dow Jones
8:00AM ET on Thursday Apr 04, 2024 by Dow Jones
Apr 3, 2024
Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules, from 4:05PM ET on Wednesday Apr 03, 2024 by Dow Jones
4:05PM ET on Wednesday Apr 03, 2024 by Dow JonesPress Release: Biora Therapeutics Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules, from 4:05PM ET on Wednesday Apr 03, 2024 by Dow Jones
4:05PM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 1, 2024
DJ Biora Therapeutics Shares Drop 26% After Pricing of Direct Offering, from 9:45AM ET on Monday Apr 01, 2024 by Dow Jones
9:45AM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biora Therapeutics Inc | 20.0M | -0.1x | --- |
Aptose Biosciences Inc | 20.0M | -0.2x | --- |
Eom Pharmaceutical Holdings Inc | 20.0M | -4.1x | --- |
Vicapsys Life Sciences Inc | 19.9M | -18.9x | --- |
Alaunos Therapeutics Inc | 19.7M | -0.6x | --- |
NKGen Biotech Inc | 19.6M | -0.2x | --- |
Company Information
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for patients with inflammatory bowel disease through treatment at the site of disease in the gastrointestinal tract. The BioJet, systemic oral delivery platform, which is designed to replace injection for better management of chronic diseases through needle-free, oral delivery of large molecules. It has two demonstration drug-device combination programs for the BioJet platform, BT-200 (GLP-1 receptor agonist) and BT-002 (adalimumab variant). Its other two programs include BT-600 (NaviCap + tofacitinib) and BT-001 (NaviCap + variant of adalimumab) for the treatment of ulcerative colitis.
Contact Information
- Headquarters
- 4330 La Jolla Village Drive, Suite 200SAN DIEGO, CA, United States 92122
- Phone
- 760-494-1555
- Fax
- 248-848-1623
Executives
- Independent Chairman of the Board
- Jeffrey Alter
- Chief Executive Officer, Director
- Aditya Mohanty
- Chief Financial Officer, Executive Vice President
- Eric D'esparbes
- Senior Vice President, General Counsel, Secretary
- Clarke Neumann
- Independent Director
- Jeffrey Ferrell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.0M |
|---|---|
Revenue (TTM) | $4.0K |
Shares Outstanding | 33.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-8.57 |
Book Value | $-4.28 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 4,989.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,678,575.00% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
